Trial Profile
An Open Label, Dose-Titration Investigation of the Pharmacokinetics, Metabolism and Safety of Testosterone Transdermal Systems in Hypogonadal Men.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Testosterone (Primary)
- Indications Hypogonadism
- Focus Pharmacokinetics
- 22 Feb 2011 Actual end date (September 2010) added as reported by ClinicalTrials.gov.
- 22 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Apr 2010 New trial record